Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Tocris Bioscience™ KRCA 0008
Potent Ack1 and ALK dual inhibitor; orally bioavailable
Specifications
Purity | >99% |
---|---|
Product Type | KRCA 0008 |
Molecular Weight (g/mol) | 609.12 |
Inhibitors | KRCA 0008 |
Description
Potent Ack1 and anaplastic lymphoma kinase (ALK) dual inhibitor (IC50 values are 4 and 12 nM respectively). Inhibits lung cancer H3122 cell proliferation (IC50 = 80 nM). Attenuates H3122 cell xenograft tumor growth in mice. Orally bioavailable.Specifications
>99% | |
KRCA 0008 | |
609.12 | |
KRCA 0008 |
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title